Global Continuous Glucose Monitoring (CGM) Market, By Component Type (Transmitters & Receivers, Sen

Published Date: | Report Code : HC1958548

X

The increasing need for the diagnosis of hyperglycemic and hypoglycemic conditions in an individual is expected to drive the growth of continuous glucose monitoring market during the forecast period. This has resulted some of the key developments by companies operating in the market to consolidate their market positions and look for further niche opportunities.

Continuous Glucose Monitoring (CGM) is generally used in order to track the glucose levels throughout the day and night. These CGM systems take glucose measurements at regular intervals, 24 hours a day, and translate the readings into dynamic data, then generate glucose direction and rate of change. Having this context not only helps CGM users proactively manage glucose highs and low but also gives added insight into impacts that meals, exercise, and illness may have on an individual’s glucose levels.

Segment Analysis:

On the basis of component type, it is segmented into transmitters & receivers, sensors, and insulin pumps. The transmitters and receivers are majorly used and preferred owing to its advantages such as user-friendly technology and increasing awareness for testing blood glucose levels in a less time frame.

By end-user, it is segregated into hospitals, homecare diagnostics, and others. The home diagnostics have seen a significant rise in its demand. These continuous glucose monitoring devices have a sensor technology that enables the testing of glucose levels without pricking fingers, and hence, does not require hospital staff intervention for operating these devices. This is one of the major factors that has impacted the growth of this segment.

Key Factors Impacting Market Growth:

  • The increasing need for the diagnosis of hyperglycemic and hypoglycemic conditions in an individual

  • Rising prevalence of chronic diseases such as diabetes all across the globe

  • Increasing awareness of healthcare amongst the consumers

Regional Analysis:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the continuous glucose monitoring market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for continuous glucose monitoring market during the forecast period. The US, Germany, France, UK, Canada, and Spain have been some of the major markets in the region.

Asia Pacific is estimated to register one of the highest CAGR for continuous glucose monitoring market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for continuous glucose monitoring market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for continuous glucose monitoring during the forecast period.

Companies Covered: Dexcom Inc., Roche Diagnostics, Medtronic plc., Novo Nordisk, Abbott Laboratories, Animas Corporation, Ypsomed AG., Bayer AG, Insulet Corporation, and Sensonic Corporation.

Market Segmentation:

By Component Type:

  • Transmitters & Receivers

  • Sensors

  • Insulin Pumps

By End User :

  • Hospitals

  • Homecare Diagnostics

  • Others

By Region:

  • North America

    • By Country (US, Canada, Mexico)

    • By Component Type

    • By End User

  • Western Europe:

    • By Country (Germany, UK, France, Spain, Rest of Western Europe)

    • By Component Type

    • By End User

  • Eastern Europe:

    • By Country (Russia, Turkey, Rest of Eastern Europe)

    • By Component Type

    • By End User

  • Asia Pacific

    • By Country (China, Japan, India, Rest of Asia Pacific)

    • By Component Type

    • By End User

  • Middle East:

    • By Country (UAE, Qatar, Iran, Saudi Arabia, Rest of Middle East)

    • By Component Type

    • By End User

  • Rest of the World

    • By Region (Latin America, Brazil, Rest of the World)

    • By Component Type

    • By End User

Reasons To Buy This Report:

  • Market size estimation of the global continuous glucose monitoring (CGM) market on a regional and global basis

  • The unique research design for market size estimation and forecast

  • Profiling of major companies operating in the market with key developments

  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment

  • By Sub-segment

  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

 Regional Analysis

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy